Skip to content

TO · WLLW.TO

Willow Biosciences Inc.

Sector
Healthcare · Drug Manufacturers - Specialty & Generic
Headquarters
Calgary, AB T2R 0Y6

Price · as of 2026-10-31

$0.04

Market cap 5.15M

Price history

The price history chart is shown only to users with a Pro subscription.

InvestorsCraft valuation

Fair value (AI, DCF / IC, Graham) for Willow Biosciences Inc. (WLLW.TO) is available to Pro members and via the machine API.

  • AI valuation — available
  • Intrinsic / IC value — available
  • Upside vs price — available

Valuation history

Annual price overlaid with each model's fair value. Y-axis is log scale.

The valuation history chart is shown only to users with a Pro subscription.

Historic valuation ratios

Pick a category, then toggle metrics to compare.

Historic valuation ratios are shown only to users with a Pro subscription.

USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Willow Biosciences Inc.

        Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical product industries in Canada. The company also produces cannabidiol, cannabigerol, and varin cannabinoids, such as cannabigerovarin, cannabidivarin, and tetrahydrocannabivarin. Willow Biosciences Inc. was incorporated in 1981 and is headquartered in Calgary, Canada.

        CEO
        Travis Doupe
        Employees
        19
        Beta
        4.65

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice.